Description:
PROTEUS SYNDROME
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases |
| Class |
Disorders of Connective Tissue, Muscle, and Bone |
|
Cell Type
|
Fibroblast
|
|
Transformant
|
Untransformed
|
|
Race
|
White
|
|
Family Member
|
1
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Clinical summary/Case history
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
| |
| Remarks |
Clinically affected; purple discoloration developed over the right leg at age 2 years; middle and index fingers on left hand were enlarged; during the second year of life toes also enlarged; plantar surfaces of feet exhibited soft-tissue overgrowth; by age 3 the vascular changes on right leg began to fade; linear pigmented plaques were noted over the axilla and extensor surface of the right arm extending to the hand; x-rays of hands showed multiple exostoses and increased bone length and width; digital shortening, phalangeal epiphysiodesis, and debulking procedures were performed on the left middle finger; because of progressive enlargement, amputation of the left middle finger was necessary at age 5; cerebriform lesions of feet; biopsy of plantar masses showed findings consistent with connective tissue nevi; multiple connective tissue hamartomata; normal cognitive development; decrease in subcutaneous tissue resulted in venous prominence and a mature facial appearance; pulmonary insufficiency with sequela of cardiac insufficiency; heart-lung transplant; normal fraternal twin brother is GM12202; parents are GM12200 and GM12201; a lymphoblast culture from this same donor is GM12203 |
| Samlaska CP, Levin SW, James WD, Benson PM, Walker JC, Perlik PC, Proteus syndrome. Arch Dermatol125:1109-14 1989 |
| PubMed ID: 2667470 |
| Split Ratio |
1:5 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
AMBIENT |
| Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not inactivated |
| Substrate |
None specified |
| Subcultivation Method |
trypsin-EDTA |
| Supplement |
- |
|
|